Intended for UK Healthcare Professionals only
This meeting has a limited number of places, your place will not be guaranteed until you receive e-mail confirmation from the meeting Secretariat.
Fields marked * are compulsory
Information marked with an '*' is required for us to fulfill your registration. If you do not provide this information you will not be able to attend the meeting. We will use the information you provide to register you for this event and to communicate with you about this event. If you give permission, we will also use the information to communicate with you on upcoming events. We will also use the information to arrange sponsorship and to comply with our obligations to publish details of payments and benefits provided to healthcare professionals. For more information and for information about your data protection rights, including to object to some processing or to ask to withdraw any permissions you have given, see the full Privacy Policy
I will attend the full meeting and will require accommodation to be booked at the meeting venue for the evening of Thursday 06 November 2025 *
Accommodation is available to all delegates should you require it. Single occupancy and breakfast costs will be covered by the meeting sponsors.
I live over 50 miles from the meeting venue and will require travel to be booked for me:*
I live within 50 miles from the meeting venue but will require parking:
The meeting Secretariat will only arrange travel for journeys that meet all necessary requirements.
Notice about your personal data processing and request for consent to individual disclosure
Teva, ABPI Code of Practice transparency and your privacy Collaboration with the healthcare community is extremely important to Teva UK Limited, and we take transparency and integrity very seriously. The Association of the British Pharmaceutical Industry Code of Practice for the Pharmaceutical Industry (ABPI Code) requires us to publicly disclose certain transfers of value that we make to healthcare professionals and other relevant decision makers, including conference registration fees, and the provision of any related travel and accommodation. This privacy notice describes how we will collect and use your personal data to help us fulfil our obligations under the ABPI Code.
Personal data we collect and why we collect it In order to manage this engagement and, where applicable, to inform the public about payments or other transfers of value provided to you we will collect and process your personal data as follows: title and full name, principal practice address, your institution or employer, work email address, and the value of applicable direct or indirect transfers made to you by Teva or its agents. Our obligation to disclose transfers of value applies regardless of whether these are provided to you at Teva’s expense or reimbursed to you. Teva means Teva UK Limited, Teva Pharmaceuticals Europe BV, Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA Inc, or its affiliated companies.
How we use and share your information Disclosure of transfers of value made to healthcare professionals and other relevant decision makers is made public annually, with data for a calendar year being published by 30 June of the following year. Disclosure will be made on the ABPI’s central ‘Disclosure UK’ platform and will include your details as outlined above, noting that email addresses are used for managing queries about your transfers of value and will not be published. We will only disclose your information where you have consented to this. If you withhold or revoke your consent, the transfers of value we make to you will be included only within aggregated statistics. Information on Disclosure UK will be in the public domain for at least three years and Teva UK Limited is obliged to maintain relevant records for a minimum of five years after the end of the relevant reporting period.
International data transfer and its safeguards Teva is a global group of companies and so your information may be transferred outside the EEA to a country that may have different data protection laws. Teva will always take steps to ensure your information is adequately protected if transferred to these countries; for example, when transferred to Teva in the USA, such transfers are protected by Teva Pharmaceuticals USA Inc’s Privacy Shield certification.
How we store information and your rights You may be entitled under applicable law to ask Teva for a copy of your information, to correct it, erase or restrict its processing, or to ask us to transfer some of this information to other organisations. You may also have rights to object to some processing and, where we have asked for your consent, to withdraw this consent. These rights may be limited in some situations – for example, where we have a legal requirement or other legal basis to process your data. As set out above, this can mean that we retain your data even if you withdraw your consent to its publication. To exercise your rights, please contact us in writing by post or e-mail at the addresses given below. We may ask you for proof of identity before complying with a request. We hope that we can satisfy any queries you may have about the way in which we process your information. If you have any concerns about how we process your data, you can get in touch using the contact details set out below. However, if you have unresolved concerns you also have the right to complain to the Information Commissioner’s Office.
Contact information The collection and disclosure of this data is controlled by Teva UK Limited (Company no. 00302461), whose registered office address is Ridings Point, Whistler Drive, Castleford WF10 5HX, tel 01977 628500, e-mail general.enquiries@tevauk.com. If you have any questions or concerns about this Privacy Notice, please e-mail EUprivacy@tevaEU.com. We will use reasonable endeavours to answer your question promptly or resolve your problem.
Please choose an option: *